Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Cost effectiveness of treatment models of care for hepatitis C: the South Australian state-wide experience
Author: Ramachandran, J.
Kaambwa, B.
Muller, K.
Haridy, J.
Tse, E.
Tilley, E.
Altus, R.
Waddell, V.
Gordon, D.
Shaw, D.
Huynh, D.
Stewart, J.
Nelson, R.
Warner, M.
Boyd, M.A.
Chinnaratha, M.A.
Harding, D.
Ralton, L.
Colman, A.
Woodman, R.
et al.
Citation: European Journal of Gastroenterology and Hepatology, 2020; 32(10):1381-1389
Publisher: Wolters Kluwer
Issue Date: 2020
ISSN: 0954-691X
Statement of
Jeyamani Ramachandran, Billingsley Kaambwa, Kate Muller, James Haridy, Edmund Tse, Emma Tilley, Rosalie Altus, Victoria Waddell, David Gordon, David Shaw, Dep Huynh, Jeffrey Stewart, Renjy Nelson, Morgyn Warner, Mark A. Boyd, Mohamed A. Chinnaratha, Damian Harding, Lucy Ralton, Anton Colman, Richard Woodman and Alan J. Wigg
Abstract: Abstract not available.
Keywords: Cost effectiveness; directly acting antiviral drugs; hepatitis C; Markov model; models of care
Rights: Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.
DOI: 10.1097/MEG.0000000000001659
Appears in Collections:Aurora harvest 4
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.